10/31/14 ZLTQ 25.64 Zeltiq Aesthetics Inc $ZLTQ Hi
Post# of 24
Posted On: 11/02/2014 4:13:02 AM
10/31/14 ZLTQ 25.64 Zeltiq Aesthetics Inc $ZLTQ Hit a 52 week high of 27.47 Closing the day 10/31/14 at 25.64 -1.01 -3.79% With a day low of 25.27 and a total volume of 968,800.
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 25.64 (-1.01), TYL: 111.92 (+1.50), SWHC: 10.16 (+0.13)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 25.64 (-1.01), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13), OMI: 33.32 (+0.27)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 47.55 (-0.04), ZLTQ: 25.64 (-1.01), EA: 40.97 (+1.12), AMED: 26.10 (+0.82)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 25.64 (-1.01), GPRE: 34.20 (+0.20), WMB: 55.51 (+0.51), OMG: 26.03 (+0.40), IPGP: 73.41 (+1.45)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 25.64 (-1.01), MDT: 68.16 (+0.73), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 25.64 (-1.01), ORB: 26.30 (+0.27), FB: 74.99 (+0.88)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 25.64 (-1.01)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 25.64 (-1.01)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 25.64 (-1.01)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 25.64 (-1.01)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 25.64 (-1.01), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13), BAX: 70.14 (+0.08)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 25.64 (-1.01)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 25.64 (-1.01), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13), RMD: 52.22 (+0.11)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 70.90 (unch), ZLTQ: 25.64 (-1.01), ABAX: 52.66 (+1.13), RMD: 52.22 (+0.11)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 495.80 (+5.80), ELOS: 9.36 (+0.17), VRX: 133.04 (+1.53), ZLTQ: 25.64 (-1.01), VAR: 84.12 (+0.12), CFN: 57.37 (-0.15), STNR: 42.18 (+0.88)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 70.90 (unch), ZLTQ: 25.64 (-1.01), ABAX: 52.66 (+1.13), CRDC: 0.98 (unch)
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 25.64 (-1.01), PAHC: 25.92 (+0.27), GWPH: 73.75 (+3.29), TRIB: 17.40 (+0.05)
Mead Johnson Tops Q3 Earnings & Revenues, Retains View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:59AM CDT
Mead Johnson (MJN) expects dairy input costs to moderate in the near future, which is believed to fuel positive growth in overall profit margins.
ZLTQ: 25.64 (-1.01), MJN: 99.31 (-4.26), GWPH: 73.75 (+3.29), QDEL: 28.55 (+0.32)
Unisys (UIS) Q3 Results Trump Estimates, Shares Shoot Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:04AM CDT
Shares of Unisys Corporation (UIS) shot up sharply after it reported impressive third-quarter 2014 results, breaking its trend after several quarters of missing estimates amid deteriorating earnings and revenues.
ZLTQ: 25.64 (-1.01), WTM: 624.92 (+4.92), UIS: 25.64 (+0.50), THRM: 41.70 (+3.60)
ZELTIQ to Present at Investor Conferences in November 2014
Marketwired - Wed Oct 22, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in various investor conferences in November 2014.
ZLTQ: 25.64 (-1.01)
ZLTQ Recent Posts: http://investorshangout.com/Zeltiq-Aesthetics...LTQ-55968/
ZLTQ Zeltiq Aesthetics Inc Recent Headline News
Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 25.64 (-1.01), TYL: 111.92 (+1.50), SWHC: 10.16 (+0.13)
Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 25.64 (-1.01), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13), OMI: 33.32 (+0.27)
Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 47.55 (-0.04), ZLTQ: 25.64 (-1.01), EA: 40.97 (+1.12), AMED: 26.10 (+0.82)
5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 25.64 (-1.01), GPRE: 34.20 (+0.20), WMB: 55.51 (+0.51), OMG: 26.03 (+0.40), IPGP: 73.41 (+1.45)
Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 25.64 (-1.01), MDT: 68.16 (+0.73), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13)
Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 25.64 (-1.01), ORB: 26.30 (+0.27), FB: 74.99 (+0.88)
Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 25.64 (-1.01)
ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 25.64 (-1.01)
Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics. Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 25.64 (-1.01)
ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 25.64 (-1.01)
Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 25.64 (-1.01), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13), BAX: 70.14 (+0.08)
3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics. Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 25.64 (-1.01)
ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 25.64 (-1.01), GWPH: 73.75 (+3.29), ABAX: 52.66 (+1.13), RMD: 52.22 (+0.11)
Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 70.90 (unch), ZLTQ: 25.64 (-1.01), ABAX: 52.66 (+1.13), RMD: 52.22 (+0.11)
Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 495.80 (+5.80), ELOS: 9.36 (+0.17), VRX: 133.04 (+1.53), ZLTQ: 25.64 (-1.01), VAR: 84.12 (+0.12), CFN: 57.37 (-0.15), STNR: 42.18 (+0.88)
Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 70.90 (unch), ZLTQ: 25.64 (-1.01), ABAX: 52.66 (+1.13), CRDC: 0.98 (unch)
Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 25.64 (-1.01), PAHC: 25.92 (+0.27), GWPH: 73.75 (+3.29), TRIB: 17.40 (+0.05)
Mead Johnson Tops Q3 Earnings & Revenues, Retains View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 11:59AM CDT
Mead Johnson (MJN) expects dairy input costs to moderate in the near future, which is believed to fuel positive growth in overall profit margins.
ZLTQ: 25.64 (-1.01), MJN: 99.31 (-4.26), GWPH: 73.75 (+3.29), QDEL: 28.55 (+0.32)
Unisys (UIS) Q3 Results Trump Estimates, Shares Shoot Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 8:04AM CDT
Shares of Unisys Corporation (UIS) shot up sharply after it reported impressive third-quarter 2014 results, breaking its trend after several quarters of missing estimates amid deteriorating earnings and revenues.
ZLTQ: 25.64 (-1.01), WTM: 624.92 (+4.92), UIS: 25.64 (+0.50), THRM: 41.70 (+3.60)
ZELTIQ to Present at Investor Conferences in November 2014
Marketwired - Wed Oct 22, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in various investor conferences in November 2014.
ZLTQ: 25.64 (-1.01)
(0)
(0)Zeltiq Aesthetics Inc. (ZLTQ) Stock Research Links
Scroll down for more posts ▼